MedPath

Could Ephedrine Replace Dexmedetomidine Fordexmedetomidine Prevention of Shivering in Women Undergoing Cesarean Section Under Spinal Anaesthesia

Not Applicable
Recruiting
Conditions
Prevention of Shivering With Spinal Anaesthesia
Interventions
Registration Number
NCT06233032
Lead Sponsor
Assiut University
Brief Summary

Could ephedrine replace dexamedetomidine for prevention of shivering in women undergoing Cesarean section Under spinal anaesthesia

Detailed Description

Shivering, rhythmic oscillatory movement of upper limbs, neck and jaw, is common during regional anesthesia with an incidence up to 56.7% of patients. Perioperative shivering is a commonly observed clinical problem well known to anesthesiologists caring for women undergoing a Cesarean delivery (CD). The median incidence of shivering in parturients having labour epidural analgesia or CD with epidural or spinal anesthesia has been estimated to be 52%.1 Severe shivering causes physiologic stress, interferes with patient monitors, and decreases the comfort and overall satisfaction of women during childbirth. Ephedrine well-known sympathomimetic agent, has been used to treat hypotension during regional anesthesia. It has antiemetic effect for short-term . Ephedrine maintained hemodynamics and minimized decrease of the core temperature when given by an intravenous infusion during spine surgery under general anesthesia . Dexmedetomidine, a selective a-2 agonist, was introduced in clinical practice in the United States in 1999. It is approved by Health Canada as a short-term sedative for mechanically ventilated adult patients in the intensive care unit and sedation of non-intubated patients prior to and/or during surgical procedures. It has since been approved and is widely used in pediatric populations and for procedural sedation of non-intubated patients.9 Nevertheless, the clinical use of dexmedetomidine has expanded to various off-label uses. In obstetrical anesthesia, it has been used as part of multi-modal intravenous labour and post-CD analgesia,10-13 as a neuraxial adjunct in the epidural space for labour,14 and intrathecally for shivering prevention during CD

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
200
Inclusion Criteria
  • Adult female from 18 to 35 yrs
  • uncomplicated pregnancy for elective cesarean delivery
Read More
Exclusion Criteria
  • patient refusal
  • allergy to the drug
  • contraindications of spinal anaesthesia
  • patients with DM or thyroid disorders
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group EEphedrine-
Group DDexmedetomidine-
Primary Outcome Measures
NameTimeMethod
Prevention of shivering during spinal anaesthesia in cesarean delivery .Intensity of shivering assessed using five point scale45min

one hundred Pts will be included in this study .

1. fifty patients will receive Ephedrine 6 mg IV bolus before spinal block.

2. fifty patients will be receive 30 microgram IV bolus before spinal block

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut university

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath